HealthXL Webinar: Digital Health: Are we at a Turning Point?

Digital health’s interaction with pharma is evolving; it has to evolve. Digital innovation around and beyond the molecule has yet to demonstrate real value, ROI and scale. While digital health found refuge with pharma initially, market observers are now questioning whether pharma should lead this digital charge or simply be a main consumer.

Digital will be a part of pharma’s future, as consumers demand the digital convenience they now take for granted in other industries. Pharma is learning from the past and focusing their efforts into high-potential initiatives.

Our upcoming HealthXL report maps out the next phase for digital health in pharma. Leading experts from across our community have shared their thoughts on driving innovation in and for the pharmaceutical industry to understand what has happened to digital health in pharma and how it’s evolving.

In this webinar, we will share the highlights from the report and have a panel discussion with forefront leaders in digital health. Join now to secure your place.‍